Boston Scientific (NYSE:BSX) today reported first-quarter financial results that came in ahead of the Wall Street forecast.

China’s rapid rise in science has hit a milestone. The country’s investment in research and development has reached parity ...

On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech ...

CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including ...

Despite Boston’s Q1 performance denoting a YoY rise of 11.2%, the company has trimmed its full-year growth outlook by 2% at the top-end.

Made Scientific, Inc., a U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Regenicin, ...

April 22 () - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a ...

Author Rachel Zoffness breaks down why we have chronic pain and how science shows that it’s all in our head ...

Millions of scientific papers are published globally every year. These papers in science, technology, engineering, mathematics, and medicine present discoveries that range from the mundane to the ...

AI has already proved itself a valuable scientific tool. Could it take on a more central role in the research process?

WisPaper, an AI-powered academic research agent, today introduced a new approach to scientific workflows that supports ...